OBJECTIVE: To define and characterize the progression of the spontaneous autoimmune disease that develops in mice in the absence of the leukocyte adhesion receptor P-selectin glycoprotein ligand 1 (PSGL-1). METHODS: Skin-resident immune cells from PSGL-1-deficient mice and C57BL/6 control mice of different ages were isolated and analyzed by flow cytometry. Biochemical parameters were analyzed in mouse serum and urine, and the presence of serum autoantibodies was investigated. Skin and internal organs were extracted, and their structure was analyzed histologically. RESULTS: Skin-resident innate and adaptive immune cells from PSGL-1(-/-) mice had a proinflammatory phenotype with an imbalanced T effector cell:Treg cell ratio. Sera from PSGL-1(-/-) mice had circulating autoantibodies commonly detected in connective tissue-related human autoimmune diseases. Biochemical and histologic analysis of skin and internal organs revealed skin fibrosis and structural and functional abnormalities in the lungs and kidneys. Furthermore, PSGL-1(-/-) mice exhibited vascular alterations, showing loss of dermal vessels, small vessel medial layer remodeling in the lungs and kidneys, and ischemic processes in the kidney that promote renal infarcts. CONCLUSION: Our study demonstrates that immune system overactivation due to PSGL-1 deficiency triggers an autoimmune syndrome with characteristics similar to systemic sclerosis, including skin fibrosis, vascular alterations, and systemic organ involvement. These results suggest that PSGL-1 expression contributes to the maintenance of the homeostasis of the immune system and could act as a barrier for autoimmunity in mice.
OBJECTIVE: To define and characterize the progression of the spontaneous autoimmune disease that develops in mice in the absence of the leukocyte adhesion receptor P-selectin glycoprotein ligand 1 (PSGL-1). METHODS: Skin-resident immune cells from PSGL-1-deficientmice and C57BL/6 control mice of different ages were isolated and analyzed by flow cytometry. Biochemical parameters were analyzed in mouse serum and urine, and the presence of serum autoantibodies was investigated. Skin and internal organs were extracted, and their structure was analyzed histologically. RESULTS: Skin-resident innate and adaptive immune cells from PSGL-1(-/-) mice had a proinflammatory phenotype with an imbalanced T effector cell:Treg cell ratio. Sera from PSGL-1(-/-) mice had circulating autoantibodies commonly detected in connective tissue-related humanautoimmune diseases. Biochemical and histologic analysis of skin and internal organs revealed skin fibrosis and structural and functional abnormalities in the lungs and kidneys. Furthermore, PSGL-1(-/-) mice exhibited vascular alterations, showing loss of dermal vessels, small vessel medial layer remodeling in the lungs and kidneys, and ischemic processes in the kidney that promote renal infarcts. CONCLUSION: Our study demonstrates that immune system overactivation due to PSGL-1 deficiency triggers an autoimmune syndrome with characteristics similar to systemic sclerosis, including skin fibrosis, vascular alterations, and systemic organ involvement. These results suggest that PSGL-1 expression contributes to the maintenance of the homeostasis of the immune system and could act as a barrier for autoimmunity in mice.
Authors: Karla M Viramontes; Emily N Neubert; Julia M DeRogatis; Monique L Henriquez; Christian F Guerrero-Juarez; Roberto Tinoco Journal: Cancer Immunol Res Date: 2022-05-03 Impact factor: 12.020
Authors: Linhui Julie Su; Jason Pinckney; David Critton; Robert J Johnston; Eric Boyer; Arathi Krishnakumar; Martin Corbett; Andrew L Rankin; Rose Dibella; Lynne Campbell; Gaelle H Martin; Hadia Lemar; Thomas Cayton; Richard Y-C Huang; Xiaodi Deng; Akbar Nayeem; Haibin Chen; Burce Ergel; Joseph M Rizzo; Aaron P Yamniuk; Sanjib Dutta; Justine Ngo; Andrea Olga Shorts; Radha Ramakrishnan; Alexander Kozhich; Jim Holloway; Hua Fang; Ying-Kai Wang; Zheng Yang; Kader Thiam; Ginger Rakestraw; Arvind Rajpal; Paul Sheppard; Michael Quigley; Keith S Bahjat; Alan J Korman Journal: Nature Date: 2019-10-23 Impact factor: 49.962
Authors: Rafael González-Tajuelo; Javier Silván; Alicia Pérez-Frías; María de la Fuente-Fernández; Reyes Tejedor; Marina Espartero-Santos; Esther Vicente-Rabaneda; Ángeles Juarranz; Cecilia Muñoz-Calleja; Santos Castañeda; Carlos Gamallo; Ana Urzainqui Journal: Sci Rep Date: 2017-02-02 Impact factor: 4.379
Authors: Rafael González-Tajuelo; Elena González-Sánchez; Javier Silván; Antonio Muñoz-Callejas; Esther Vicente-Rabaneda; Javier García-Pérez; Santos Castañeda; Ana Urzainqui Journal: Front Immunol Date: 2020-11-12 Impact factor: 7.561
Authors: Rafael González-Tajuelo; María de la Fuente-Fernández; Daniel Morales-Cano; Antonio Muñoz-Callejas; Elena González-Sánchez; Javier Silván; Juan Manuel Serrador; Susana Cadenas; Bianca Barreira; Marina Espartero-Santos; Carlos Gamallo; Esther F Vicente-Rabaneda; Santos Castañeda; Francisco Pérez-Vizcaíno; Ángel Cogolludo; Luis Jesús Jiménez-Borreguero; Ana Urzainqui Journal: Arthritis Rheumatol Date: 2020-01-28 Impact factor: 10.995